Neoadjuvant nivolumab/ipilimumab shows promise in resectable NSCLC Presented ByDr Tina Cascone, University of Texas MD Anderson Cancer Centre, USA TrialNEOSTAR ConferenceASCO 2019 TypePeer-reviewed article 15 July 2019 23:59